The King Abdulaziz Medical City in Riyadh is getting ready to open a stem cell bank harvested from the umbilical cord. The procedure will be done in laboratories and specially equipped rooms to draw the cells from umbilical cord blood and separate them using a special device.
Then they will be stored in labs for a period from 15 to 20 years after examining them and making sure they are free of contagious and genetic diseases. In addition, a team will be prepared for coordinating, marketing and research within this field.
Italy is the top country in the world for hematopoietic stem cell transplants per million inhabitants, said Alessandro Nanni Costa, the director of the National Transplant Center (CNT), presenting data today in Rome from a study by the Welfare Minister on umbilical cord stem cells.
Italy boasts a registry of 370,000 healthy adults available to donate blood stem cells.
The units of umbilical cord blood preserved in Italian biobanks number 17,503, while in 2008, only 141 were used in Italy or abroad.
The objective is to reach 80,000-90,000 units of umbilical cords preserved from which blood stem cells can be removed
CHENNAI – The country’s first public stem cell bank has stopped accepting cord blood donations.
After processing and storing stem cells from cord blood of 569 women since February 2009, Jeevan Stem Cell Bank has put its operations on hold owing to lack of funds. The bank hopes that the situation will soon change, and it can restart operations once more donations come in.
Private banks charge anywhere up to Rs 1.5 lakh for extraction and preservation of these cells, but Jeevan, which started with an initial investment of Rs 3 crore, depends on public goodwill and corporate donations. The
(…) Since 2006, according to NECBB records, the number of banked units used in transplants has doubled. The company attributes this increase in cord blood usage to the ever evolving research surrounding cord blood stem cells.
“We have always reminded parents that stem cell therapies are advancing very quickly and it is difficult to know what the possibilities are. The fact that more parents are using cells they stored suggests that the scope of treatments available is encouraging,” said Dr. David Matzilevich, Chief Scientific Officer of NECBB. “We are confident that the cells found in cord blood are extremely valuable